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Abstract
Background: A longer leukocyte telomere length (LTL) in women than men has been
attributed to a slow rate of LTL attrition in women, perhaps due to high estrogen expos-
ure during the premenopausal period.
Methods: To test this premise we performed a longitudinal study (an average follow-up
of 12 years) in a subset of the population-based Danish National Twin Registry.
Participants consisted of 405 women, aged 37.5 (range 18.0–64.3) years, and 329 men,
aged 38.8 (range 18.0–58.5) years, at baseline examination.
Results: Women showed a longer LTL [kb6 standard error(SE)] than men (baseline:
7.016 0.03 vs 6.8760.04; follow-up: 6.7960.03 vs 6.6560.03; both P¼0.005). Women
displayed deceleration of LTL attrition (bp/years6SE), as they transitioned from the pre-
menopausal period (20.66 1.0) through the perimenopausal period (16.56 1.3) to the
postmenopausal period (15.16 1.7). Age was not associated with LTL attrition in women
after statistical control for menopausal status. Men, in contrast, displayed a trend for
age-dependent increase in the rate of LTL attrition, which differed significantly from the
pattern in women (P for interaction¼ 0.01).
Conclusions: Results indicate that the premenopausal period is expressed in a higher
rate of LTL attrition than the postmenopausal period. They further suggest that the sex
VC The Author 2015. Published by Oxford University Press on behalf of the International Epidemiological Association 1688
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
International Journal of Epidemiology, 2015, 1688–1695
doi: 10.1093/ije/dyv165









roningen user on 04 June 2019
gap in LTL stems from earlier ages—the period of growth and development. The higher
rate of LTL attrition in premenopausal women, we propose, might relate to estrogen-
mediated increased turnover of erythrocytes, menstrual bleeding or both.
Key words: Telomeres, women, men, menopause
Introduction
Women typically have a longer leukocyte telomere length
(LTL) than men.1–4 The underlying causes of this LTL sex
difference, though poorly understood, are important because
a long LTL is associated with resistance to ageing-related ath-
erosclerotic cardiovascular disease5,6 and with longevity.7–10
The prevailing view, derived from cross-sectional studies,11 is
that a slower rate of age-dependent LTL attrition in women
explains the LTL sex gap. However, two longitudinal studies
reported conflicting findings. Chen et al.12 showed that the
rate of LTL attrition was slightly slower in premenopausal
women than men (by 4.5 bp/year, P¼ 0.04), whereas a subse-
quent study by Kark et al.13 suggested that the rate of LTL at-
trition was slightly more rapid in premenopausal women (by
2.5 bp/year, P¼ 0.081). Thus, the effect of sex and meno-
pausal status on LTL attrition warrants scrutiny, and its rela-
tion to the LTL sex gap remains unresolved.
A slower LTL attrition in women, if true, might stem from
the effect of estrogen on telomerase, the reverse transcriptase
that adds telomere repeats to the ends of chromosomes.14 As
an estrogen-response element is present in the promoter of
the catalytic subunit of telomerase, estrogen can potentially
stimulate telomerase15 to attenuate the rate of age-dependent
LTL shortening in premenopausal women and thereby ex-
plain, at least in part, the LTL sex gap. Although telomerase
activity is repressed in somatic tissues during extra-uterine
life, it is not totally absent from highly proliferative tissues
such as the haematopoietic system and skin.16 Accordingly,
we tested the dual proposition that the rate of LTL attrition
differs by menopausal status and that a putatively slower rate
of LTL attrition during the premenopausal period partly
explains the longer LTL in women than in men. Our findings
support the first proposition, but cast doubt on the latter one.
Methods
Subjects
Healthy subjects were originally recruited through the popu-
lation-based Danish National Danish Twin Registry17,18 to
participate in the GEMINAKAR Study of metabolic dis-
orders and cardiovascular risk factors, performed in Odense
and Copenhagen, Denmark. For this specific investigation,
the sample consisted of 338 same-sex (SS) twin pairs (i.e.
676 twins) and 72 opposite-sex (OS) twin pairs (i.e. 144
twins). In total, 75 twin SS and 11 twins OS were excluded
due to the absence of LTL measurements either at the first
or at the second visit. Thus, all subjects included in this ana-
lysis had data on LTL measurements, BMI, smoking status
and menopause status for women in both baseline and fol-
low-up visits. We used the GEMINAKAR Study not for its
twin structure but because of the availability of longitudinal
leukocyte DNA samples for LTL measurements and wealth
of phenotypic data that included menopausal status. At
baseline, participants were without clinical evidence of dia-
betes or cardiovascular disease. Participants underwent
comprehensive anthropometric examination and provided
relevant information and blood samples approximately 12
years apart. Women with pathological menopause, namely
women subjected to oophorectomy and/or hysterectomy
(n¼ 32) and those reporting menopause (absence of menses
for at least 1 year) at age< 42 years (n¼22) were included.
The mean age of menopause in this cohort was 47.46 6.0
Key Messages
• Women have a longer leukocyte telomere length than men, a finding that was attributed to estrogen stimulating telo-
merase and thus attenuating age-dependent leukocyte telomere length rate of attrition during the premenopausal
period.
• In this longitudinal study we show that the rate of age-dependent leukocyte telomere length attrition is faster during
the premenopausal period than postmenopausal period and that regardless of menopausal status leukocyte telomere
length is longer in women than men.
• Findings suggest that the sex difference in leukocyte telomere length is largely established prior to adulthood, i.e.,
during the first two decades of life.
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years. We stratified women participants into three catego-
ries: postmenopausal women, i.e. women who had meno-
pause before the baseline examination; perimenopausal
women, i.e. women who experienced menopause (i.e. the
absence of menses for 1 year) between baseline and follow-
up examinations; and premenopausal women, i.e. women
who did not reach menopausal age at follow-up examin-
ation. The study was approved by the Regional Scientific
Ethical Committees for Southern Denmark (S-20090065)
and the Danish Data Protection Agency (2013-41-1556).
All participants provided written informed consent.
Leukocyte telomere length (LTL) measurements
We performed measurement of the terminal restriction
fragments by Southern blots as previously described.19
Measurements were performed in duplicate on different
gels and analyses are based on the averages of these two
measurements. The inter-assay coefficient of variation for
the duplicate measures was 1.3%.
Statistical analysis
In previous work on the same cohort,20 we showed that
among SS twins, as reported for singletons in the general
population, females had a longer LTL than males. In con-
trast, LTL of females from OS twins was indistinguishable
from that of males from either OS or SS twins, and was
shorter than LTL of females from SS twins. In addition,
there was no evidence in the previous work that LTL or
LTL attrition differed between mono- and dizygotic twins.
For these reasons, in our analyses we controlled for twin
type (OS vs SS), interacting with sex and age, but ignored
zygosity throughout (Tables 1 and 2). Data were analysed
with general linear mixed models, including twin identity
as a random effect because LTL measurements of co-twins
are not statistically independent. Including body mass
Table 1. Longitudinal analysis of LTL (kb) in relation to age and twin sex composition (opposite-sex vs
same-sex)






49.72 (1, 276.8) <0.0001
Delta (D) age 0.0262
(0.0327, 0.0197)
663.31 (1, 401.2) <0.001
OS 0.230
(0.391, 0.070)
7.83 (1, 297.6) 0.0055
D Age * OS 0.0065
(0.0024, 0.0106)
10.03 (1, 401.2) 0.0017
D Age * average age 0.00016
(0.000023, 0.000297)
4.41 (1, 401.2) 0.036






28.69 (1, 259.1) <0.0001
Delta (D) age 0.0142
(0.0213, 0.0071)
15.82 (1, 326.7) <0.0001
OS 0.042
(0.206, 0.122)
0.253 (1, 233.6) 0.62
D Age * OS 0.0067
(0.0030, 0.0104)
11.81 (1, 328) 0.0007
D Age * average age 0.00012
(0.00028, 0.000037)
2.51 (1, 326.7) 0.11
CI, confidence interval; OS, opposite sex; SS, same sex.
OS was coded 1 for OS twins and 0 for same-sex (SS) twins.
Twin identity and individual identity, nested in twin identity, were included as random effects.
aFor women, n¼ 841, R2¼ 0.983.
bFor men, n¼ 693, R2¼0.984.
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Table 2. Longitudinal analysis of womena LTL (kb) in relation to menopausal stage, age and twin sex
composition (opposite sex vs same sex)
Estimate (95% CI) F (df) P
Intercept
Average age – 28.86 (1, 396.4) <0.0001
Delta (D) age – 484.13 (1, 399.3) <0.0001
Opposite sex (OS) – 7.71 (1, 296.9) 0.0058
D Age * OS – 9.54 (1, 399.3) 0.0021
Menopause stage – 0.0257 (2, 385.5) 0.97










Menopause is a fixed effect factor coding for pre-, peri- and postmenopausal.
an¼ 839; R2¼ 0.984.
Figure 1. Leukocyte telomere length vs age in men and women; y, years. Data of baseline examination are presented in the upper panels and data of
the follow-up examination are presented in the lower panels. Parameters of the linear regressions are displayed in each of the panels (from model
including twin identity as random effect; R2 in the graphs refer to increase in R2 due to the age effect, given the twin identity effect).
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index (BMI) or smoking status in the model did not affect
the results (data not shown), and for simplicity we there-
fore excluded these factors from the models. Because of the
complexity of the longitudinal analyses, we analysed the
sexes separately and subsequently pooled the data sets to
test interactions with sex for the pertinent results.
Individuals were examined twice. We partitioned age at
examination into two variables: the average age at examin-
ation and the deviation in age of each individual for each
examination from the average age for that individual. For
example, for an individual whose LTL was measured at
ages 20 (baseline examination) and 30 (follow-up examin-
ation), the average age is 25 for both examinations,
whereas the age difference (delta) is 5 and þ5 for the
baseline examination and follow-up examination, respect-
ively. This procedure yields an unbiased estimate of the
within-individual effect of age on LTL.
Analyses were performed using JMP 9.0.1.
Results
General characteristics of the subjects are displayed in
Table S1 (available as Supplementary data at IJE online).
Women showed a longer LTL (kb; mean6 SE), than men
both at baseline (7.016 0.03 vs 6.796 0.03; P¼ 0.005)
and at follow-up (6.876 0.04 vs 6.656 0.03; P¼0.005).
Based on cross-sectional analysis, both women and men
displayed inverse relations between LTL and age at the
baseline and follow-up examinations (Figure 1).
Applying the model described under Methods, we first
examined the within-individual effect of age on LTL attri-
tion by testing the interaction between the deviation in age
of each individual at each examination from the average
age for that individual (delta age) and the mean age. We
found an interaction between delta age and mean age for
women, and there was a trend for men (Table 1). More im-
portantly, the signs of the interactions were opposite, such
that LTL attrition decreased with average age in women
and it increased with average age in men (three-way inter-
action Sex * Average age * Delta age: F1, 728.1¼6.64,
P¼ 0.01). Notably, despite the sex difference in the de-
pendence of LTL attrition on age, when ignoring average
age at sampling there was no difference between the sexes
in the rate of LTL attrition (interaction sex * delta age:
F1,730¼ 0.05, P¼0.8; men: 18.46 0.8 (bp/year;
mean6 SE), women: 18.56 0.7), indicating that the overt
sex differences evident during early and later life cancelled
each other out in this sample.
Next we tested whether the slowing down of LTL attri-
tion with age in women could be attributed to menopausal
status as opposed to age per se. When replacing the average
age* delta age interaction in the model in Table 1A with
both menopausal status and its interaction with delta age
(Table 2), we detected this interaction with the rate of LTL
attrition decreasing from pre-, to peri-, to postmenopausal
state (Figure 2). In this analysis (Table 2), menopausal sta-
tus is confounded by age. To test whether menopausal sta-
tus may explain the association of average age with LTL
attrition, we added the interaction between average age
and delta age to the model in Table 2. In this expanded
model (not shown), there was no evidence for interaction
between average age and delta age (F1,398.3¼0.14,
P¼ 0.7), whereas the interaction between menopausal sta-
tus and delta age was attenuated but persisted
(F2,398.3¼ 3.25, P< 0.04). Thus we conclude that meno-
pausal status is associated with LTL attrition independ-
ently of age. Notably, a subset of the women had
experienced pathological menopause (see Methods), but
results held when these women were excluded (Figure S1,
available as Supplementary data at IJE online).
We tested whether hormone replacement therapy was
associated with LTL, since 17.7% of women responded af-
firmatively to the question whether or not they had ever
used hormone replacement therapy. We tested this both by
itself and in interaction with delta age in models presented
in Table 1A and Table 2. Neither use of hormone replace-
ment therapy nor its interaction with delta age yielded an
increase in the explained variance (all P> 0.3) or substan-
tially changed the other estimates. Similarly, we tested
whether the use of oral contraceptives at baseline was asso-
ciated with LTL and/or LTL attrition. Reported oral con-
traceptive intake was 20.9% for premenopausal women,
and 7.5% for perimenopausal women. To test for possible
effects of oral contraceptive use, we selected premeno-
pausal women and tested the effect by itself and in
Figure 2. Comparisons of leukocyte telomere length attrition between
women and men. Comparisons between women and men are based on
the menopausal status of the women and the age of the men at the fol-
low-up examination, which falls in the range of the age of the women
categorized for their specific status; y, years. Data are presented as
mean6SE. For details, see text and Tables 2 and 3.
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interaction with delta age by adding these terms to the
model presented in Table 1A. Neither use of oral contra-
ceptives nor its interaction with delta age yielded a signifi-
cant increase in the explained variance (both P> 0.4).
Based on these findings, we repeated the sex comparison
in Table 2 for different menopausal stages. To this end, the
data for men were assigned to one of three age groups corres-
ponding to the ages of the menopausal stages in women (see
Subjects and Methods for details). The association of meno-
pausal stage with telomere attrition differed between the
sexes (three-way interaction menopause stage * sex * delta
age: F2,724.9¼ 5.05, P¼0.007). The comparisons between
the sexes for the different menopausal stages showed that in
younger individuals (premenopausal) LTL attrition was
higher in women than in men (F1,322.8¼2.22, P¼ 0.10), in
middle age (perimenopausal) there was no difference and in
the older individuals (postmenopausal) attrition was higher
in men than in women (F1,152¼ 6.11, P<0.02).
Discussion
Women have a longer LTL than men,1–4 as confirmed in
the present study. The sex difference in LTL might stem
from sex-related differences in LTL dynamics before adult-
hood or it could arise later if women have a lower rate of
LTL attrition. We tested the latter hypothesis through lon-
gitudinal evaluations of the rates of LTL attrition in the
two sexes. Our findings provide an unexpected portrayal
of LTL dynamics in adults.
We found that LTL attrition decreased with age in
women, whereas there was a trend for an increase in LTL at-
trition with age in men. This implies that the outcome of a
comparison of LTL attrition between the sexes will depend
on the age of the sample. The findings of Kark et al.13 based
on a longitudinal study of 13 years and a mean age of 30
years at baseline, are consistent with this conclusion. In that
study, women who were almost entirely in the premeno-
pausal period exhibited slightly faster rates of LTL attrition
than men of the same age. A more recent longitudinal study
of 6.6 years’ duration, using a qPCR-based method to meas-
ure LTL, observed a sex x age interaction in LTL attrition21
with faster LTL attrition in men than in women. Menopause
was not taken into consideration. As age at baseline examin-
ation in that study was 48 years, which is equivalent to the
mean menopausal age of 47.4 years in the present study, its
findings are also consistent with our conclusion.
More detailed analysis showed that among women the
premenopausal period was marked by a faster rate of LTL
attrition than the postmenopausal period. The LTL attri-
tion rate during perimenopause was intermediate between
the premenopausal and postmenopausal LTL attrition
rates, but was closer to the postmenopausal rate than to
the premenopausal rate, suggesting that LTL attrition had
already slowed down before menopause.
Collectively, this body of data suggests that the sex dif-
ference in LTL attrition rate, across the age span studied,
stems from the impact of menopausal status on LTL attri-
tion in women. However, telomerase stimulation by en-
dogenous estrogen and its anti-oxidative effect through
mitochondrial action22 during the premenopausal period
are unlikely to explain the longer LTL in women than men,
since the rate of LTL attrition during the premenopausal
period was in fact faster than that during the postmeno-
pausal period. We found no effect of exogenous estrogen
intake on the rate of LTL attrition. However, since only a
small subset of women were on oral contraceptives or hor-
mone replacement therapy, power to detect the effect of ex-
ogenous estrogen on LTL attrition was limited.
LTL attrition largely reflects the asymmetrical replica-
tion of haematopoietic stem cells (HSC).23,24 As the ratio
between erythrocytes and leukocytes in the blood cell mass
is800 to 125, the vast size of the erythrocyte pool is the
principal driving force of HSC asymmetrical replication. In
that light a recent work shows that, in mice, estrogen en-
hances erythrocyte turnover by stimulating HSC asymmet-
rical replication in concert with increasing erythrocyte
destruction.26 The outcome of this phenomenon, if ex-
tended to humans, would be a faster LTL attrition during
the premenopausal period, as found in our study.
Menstrual bleeding might be another potential explan-
ation for the faster LTL attrition in premenopausal women.
The average blood loss per menstrual period is estimated at
40 ml, although with a wide range.27 This amounts
to 500 ml/year, which may account at least in part for the
findings of the faster rate of LTL attrition in premenopausal
vs postmenopausal women. Diminished menstruation as
women approach menopause might also explain the finding
that LTL attrition during perimenopause was closer to the
postmenopausal rate than to the premenopausal rate.
Our longitudinal evaluation overcomes the serious
shortcomings of assessing rates of LTL attrition based on
cross-sectional studies, which consist of individuals of dif-
ferent ages whose LTL is highly variable for a given age
(3 kb, Figure 1). Whereas longitudinal evaluation of LTL
attrition provides direct observations of the individual’s
rate of attrition, inference from these observations is con-
strained by the error of telomere length measurements in
relation to the duration of the follow-up.28 We would like
to emphasize, however, that although confidence in our
findings is reasonably high (given the average 12-year dur-
ation of the follow-up and the low measurement error of
the Southern blots of LTL), the findings are inconsistent
with the previous prevailing view; therefore, they invite
replication in future longitudinal studies.
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In addition, for the following reasons the potential ex-
planations we offer for our findings should be guarded. First,
we propose that the higher rate of LTL attrition in premeno-
pausal women might stem from a higher turnover of HSCs
based on data derived from mice; whether this finding ex-
tends to humans remains to be verified. Second, with regard
to the potential impact of menstrual blood loss on LTL attri-
tion, we have no detailed information in this study about the
extent of menstrual bleeding in the women participants, nor
how it compares in scale with total erythrocyte turnover.
Third, pregnancy entails an increase in the maternal blood
volume which, in principle, might impact on the rate of LTL
attrition during the reproductive years. However, in this
study no data were available about reproduction during the
follow-up period. Finally, our findings are based on data in
healthy twins, free of diabetes and cardiovascular disease at
the baseline examination, and both co-twins had to survive
to the follow-up examination. Thus, our healthy cohort of
twins may not be representative of the general population,
which might explain, for instance, the low rate of age-de-
pendent LTL attrition we report in this study.
Based on direct and indirect assessments of LTL dy-
namics during early life,28–31 previous studies have reached
the conclusion that the longer LTL in women than men is
the outcome of a difference established before adulthood. In
a small study consisting of three ethnic groups (Whites of
European ancestry, African Americans and Hispanics), LTL
in newborn girls was found to be longer by 57 bp than that
in boys.32 However, this difference was not statistically sig-
nificant. In light of our findings, large-scale studies are war-
ranted to establish whether the sex difference in LTL stems
from a longer LTL in newborn girls than boys, a slower
LTL attrition during childhood in girls than boys, or both.
Having more clarity as to the origin of the sex gap in
LTL might lead to mechanistic understanding of factors
that drive LTL dynamics. This will be highly relevant to
public health, given that short LTL entails an increased
risk for atherosclerotic heart diseases in adults5 and dimin-
ished longevity.7–10 Whether telomeres play a causal role
in atherosclerosis and longevity remains unresolved, but a
growing body of evidence points to such a possibility.
Supplementary data
Supplementary data ate available at IJE online.
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